As to uterine serous carcinoma/uterine papillary serous carcinoma, the most common alterations were the high mRNA expression of all CDCA members, the amplification of CDCA5, CBX2 and CDCA8 and the missense mutation of CDCA2/7. This evidence concerns the gene CBX2 and endometrial serous adenocarcinoma.